伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688580 伟思医疗

已收盘 11-22 15:00:01

{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":28.81,"timestamp":1732258801000,"preClose":30.59,"halted":0,"volume":865109,"delay":0,"floatShares":95771299,"shares":95771299,"eps":1.1773,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.78,"latestTime":"11-22 15:00:01","open":30.59,"high":30.59,"low":28.55,"amount":25640800,"amplitude":0.0667,"askPrice":28.81,"askSize":2,"bidPrice":28.67,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.1773,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":30.59,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":33.65,"lowLimit":27.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95771288,"pbRate":1.71,"roa":"--","roe":"4.8%","epsLYR":1.9969,"committee":-0.520325,"marketValue":2759000000,"floatMarketCap":2759000000,"peRate":24.471248,"changeRate":-0.0582,"turnoverRate":0.009,"status":1,"afterMarket":{"amount":0,"volume":0,"close":28.81,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":30.59}},"requestUrl":"/m/hq/s/688580/wiki","defaultTab":"wiki","newsList":[{"id":"2485233695","title":"11月22日伟思医疗跌5.82%，前海联合泳涛混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233695","media":"证券之星","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233695?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:22","pubTimestamp":1732263758,"startTime":"0","endTime":"0","summary":"证券之星消息，11月22日伟思医疗跌5.82%，收盘报28.81元，换手率0.9%，成交量8651.0手，成交额2564.08万元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为前海联合泳涛混合A。前海联合泳涛混合A目前规模为0.14亿元，最新净值1.2549，较上一交易日下跌0.44%，近一年下跌17.33%。前海联合泳涛混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200025898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2485328961","title":"伟思医疗跌5% 7家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485328961","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485328961?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:39","pubTimestamp":1732257575,"startTime":"0","endTime":"0","summary":"11月22日，伟思医疗股价大幅下跌，截至14点39分，伟思医疗下跌5.20%，报29.00元/股，失守30元整数关口，成交2236万元，换手率0.78%，振幅5.20%。此外，数据统计显示，近半年内7家券商给予增持建议，9家券商给予买入建议。资金动向截止发稿，伟思医疗获得主力净流出301万元，其中超大单流出77万元，大单流出223万元。最新财报显示，今年三季报，伟思医疗实现营业收入2.92亿元，同比减少12.06%，净利润为7,816.63万元，同比减少23.13%，基本每股收益为0.82元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145555a24d33da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145555a24d33da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2484697617","title":"伟思医疗获2项医疗器械注册证 涉及多功能生物刺激反馈仪","url":"https://stock-news.laohu8.com/highlight/detail?id=2484697617","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484697617?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:02","pubTimestamp":1731916968,"startTime":"0","endTime":"0","summary":"财中社11月18日电伟思医疗 发布关于自愿披露取得医疗器械注册证的公告。公司近日收到了江苏省药品监督管理局颁发的2项《医疗器械注册证》，包括多功能生物刺激反馈仪和生物刺激反馈仪。多功能生物刺激反馈仪主要用于神经和肌肉功能的恢复，适用于多种病症，广泛运用于医院的神经康复科室。文章来源：财中社伟思医疗获2项医疗器械注册证 涉及多功能生物刺激反馈仪","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118160925a2424f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118160925a2424f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580","159883"],"gpt_icon":0},{"id":"2484112726","title":"伟思医疗(688580.SH)取得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112726","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484112726?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:36","pubTimestamp":1731915402,"startTime":"0","endTime":"0","summary":"智通财经APP讯，伟思医疗(688580.SH)发布公告，公司于近日收到了由江苏省药品监督管理局颁发的2项《医疗器械注册证》，产品名称：多功能生物刺激反馈仪、生物刺激反馈仪。上述拿证的多功能生物刺激反馈仪产品主要是用于神经和肌肉受损功能的恢复，是市场主流的康复物理治疗产品，广泛运用于医院神经康复相关科室。新款生物刺激反馈仪是公司原有盆底电刺激产品的全面升级迭代，主要是用于各类盆底功能障碍疾病的治疗，广泛运用于医院妇产、盆底中心相关科室。上述《医疗器械注册证》的取得，将有利于进一步扩展和优化公司物理因子治疗产品线，提升公司电刺激类产品在盆底康复与康复理疗市场的综合竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","09997","BK0251","09996","BK1222","688580","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2483636312","title":"伟思医疗（688580）11月14日主力资金净卖出952.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483636312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483636312?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:25","pubTimestamp":1731630322,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月14日收盘，伟思医疗报收于30.9元，下跌5.45%，换手率1.51%，成交量1.44万手，成交额4606.43万元。伟思医疗主营业务：主要从事医疗器械的研发、生产和销售,以研发创新为发展驱动力,持续投入在电刺激、磁刺激、电生理、康复机器人以及医美能量源等方向的先进技术研发,并完善产品布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500006707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2483609846","title":"伟思医疗11月14日遭主力抛售831万元 环比增加160.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483609846","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483609846?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:20","pubTimestamp":1731568810,"startTime":"0","endTime":"0","summary":"11月14日, 伟思医疗股价跌5.45%，报收30.90元，成交金额4606万元，换手率1.51%，振幅7.31%，量比0.81。伟思医疗今日主力资金净流出831万元，上一交易日主力净流出319万元，今日环比增加160.50%。该股近5个交易日下跌2.34%，主力资金累计净流入686万元；近20日主力资金累计净流入663万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153723a2368ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153723a2368ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2483181009","title":"伟思医疗大跌5.14% 7家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483181009","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483181009?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:51","pubTimestamp":1731567088,"startTime":"0","endTime":"0","summary":"11月14日，伟思医疗股价大幅下跌，截至14点51分，伟思医疗下跌5.14%，报31.00元/股，成交4302万元，换手率1.40%，振幅6.95%。此外，数据统计显示，近半年内7家券商给予增持建议，9家券商给予买入建议。资金动向截止发稿，伟思医疗获得主力净流出695万元，其中超大单流出442万元，大单流出252万元。最新财报显示，今年三季报，伟思医疗实现营业收入2.92亿元，同比减少12.06%，净利润为7,816.63万元，同比减少23.13%，基本每股收益为0.82元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145138a2366417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145138a2366417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2482484776","title":"伟思医疗：累计回购约43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482484776","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482484776?lang=zh_cn&edition=full","pubTime":"2024-11-12 18:08","pubTimestamp":1731406108,"startTime":"0","endTime":"0","summary":"每经AI快讯，伟思医疗 11月12日晚间发布公告称，截至2024年11月10日，公司通过上海证券交易所交易系统以集中竞价方式累计回购公司股份约43万股，占公司总股本约9577万股的比例为0.4447%，回购成交的最高价为65.88元/股，最低价为21.8元/股，支付的资金总额为人民币约2004万元。2023年1至12月份，伟思医疗的营业收入构成为：医疗器械占比93.94%，其他占比4.59%。截至发稿，伟思医疗市值为32亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112180950a230208c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112180950a230208c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2482782196","title":"伟思医疗最新公告：选举王志愚为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2482782196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482782196?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:00","pubTimestamp":1731333612,"startTime":"0","endTime":"0","summary":"伟思医疗公告，选举王志愚为公司第四届董事会董事长，任期自本次董事会审议通过之日起至第四届董事会任期届满之日止。同时，公司聘任王志愚为总经理。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100029063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2482785018","title":"伟思医疗选举王志愚为董事长兼总经理 童奕虹为董秘","url":"https://stock-news.laohu8.com/highlight/detail?id=2482785018","media":"财中社","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482785018?lang=zh_cn&edition=full","pubTime":"2024-11-11 20:19","pubTimestamp":1731327558,"startTime":"0","endTime":"0","summary":"财中社11月11日电伟思医疗 发布关于选举董事长、董事会专门委员会委员、监事会主席及聘任高级管理人员、证券事务代表的公告。王志愚被选为董事长，胡平被选为监事会主席。此外，公司还公布了第四届董事会各专门委员会的成员名单，并聘任了包括王志愚在内的多位高级管理人员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111203958a22ca2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111203958a22ca2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2482227346","title":"伟思医疗11月11日主力资金流入418万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482227346","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482227346?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:20","pubTimestamp":1731309650,"startTime":"0","endTime":"0","summary":"伟思医疗今日主力资金净流入418万元，连续3日净流入，上一交易日主力净流入337万元，今日环比增加24.04%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为70.00%，平均涨幅为2.09%。该股近5个交易日上涨15.79%，主力资金累计净流入1113万元；近20日主力资金累计净流入281万元，其中净流入天数为9日。该行业中净流入前三个股分别为联影医疗、凯利泰、爱博医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153518abb53971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153518abb53971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2482227641","title":"伟思医疗创1个月新高 陕西推动养老金融高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2482227641","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482227641?lang=zh_cn&edition=full","pubTime":"2024-11-11 14:44","pubTimestamp":1731307456,"startTime":"0","endTime":"0","summary":"11月11日，伟思医疗股价大幅上涨，截至14点44分，伟思医疗上涨5.18%，报33.29元/股，创近1个月新高，成交4436万元，换手率1.43%。消息解读陕西金融监管局11月11日发文称，联合开展金融支持养老产业千亿行动，推动养老金融高质量发展。最新财报显示，今年三季报，伟思医疗实现营业收入2.92亿元，同比减少12.06%，净利润为7,816.63万元，同比减少23.13%，基本每股收益为0.82元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111144732abb508ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111144732abb508ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159940","688580","BK0251"],"gpt_icon":0},{"id":"2481942657","title":"伟思医疗涨5.00% 8家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2481942657","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481942657?lang=zh_cn&edition=full","pubTime":"2024-11-07 14:50","pubTimestamp":1730962207,"startTime":"0","endTime":"0","summary":"11月07日，伟思医疗股价大幅上涨，截至14点50分，伟思医疗上涨5.00%，报31.50元/股，创近1个月新高，成交4391万元，换手率1.48%，振幅5.67%。此外，数据统计显示，近半年内8家券商给予增持建议，10家券商给予买入建议。最新财报显示，今年三季报，伟思医疗实现营业收入2.92亿元，同比减少12.06%，净利润为7,816.63万元，同比减少23.13%，基本每股收益为0.82元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107145021aba8e823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107145021aba8e823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2481280556","title":"伟思医疗：公司目前已形成覆盖上下肢较为全面的康复机器人产品矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2481280556","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481280556?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:01","pubTimestamp":1730880085,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：董秘您好，公司生产的机器人主要用在那些方面，谢谢？伟思医疗（688580.SH）11月6日在投资者互动平台表示，公司目前已形成覆盖上下肢较为全面的康复机器人产品矩阵，可应用于康复科、康复专科医院、骨科、神经科等，协助截瘫、偏瘫等患者恢复站立行走能力，协助脊髓损伤、脑卒中或其他神经系统疾病导致的运动功能障碍患者进行康复训练。后续公司将进一步降本增效，不断提高康复机器人产品市场竞争力，覆盖更多临床康复应用场景(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106160243aba5606a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106160243aba5606a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0073","BK0028","BK0196","BK0251","688580","BK0259","BK0061","BK0089","BK0122","BK0188","BK0130","BK0005","300024","159526"],"gpt_icon":0},{"id":"2481628056","title":"伟思医疗：有脉冲光相关产品在研","url":"https://stock-news.laohu8.com/highlight/detail?id=2481628056","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481628056?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:57","pubTimestamp":1730879824,"startTime":"0","endTime":"0","summary":"格隆汇11月6日丨伟思医疗(688580.SH)在投资者互动平台表示，公司目前的激光类产品，主要包括皮秒激光治疗仪和科瑞达钬激光治疗机，其中皮秒激光具有治疗皮肤色素类疾病、去除纹身等功能，主要应用于皮肤科、激光科、医学美容科等；科瑞达钬激光治疗机主要应用于泌尿外科的泌尿系统碎石手术；与此同时，公司也有脉冲光相关产品在研。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106160138aba55df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106160138aba55df7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2479281089","title":"伟思医疗：业绩说明会定于11月15日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2479281089","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479281089?lang=zh_cn&edition=full","pubTime":"2024-10-31 20:24","pubTimestamp":1730377466,"startTime":"0","endTime":"0","summary":"每经AI快讯，伟思医疗 10月31日晚间发布公告称，公司2024年第三季度业绩说明会定于2024年11月15日(星期五)下午13:00-14:00，以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有：公司董事长兼总经理王志愚，副总经理、董事会秘书钟益群，董事、财务总监陈莉莉，独立董事肖俊方。伟思医疗的总经理、董事长均是王志愚，男，57岁，学历背景为硕士。截至发稿，伟思医疗市值为28亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031202519a201ba3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031202519a201ba3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2479214196","title":"华安证券：给予伟思医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479214196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479214196?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:58","pubTimestamp":1730260690,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对伟思医疗进行研究并发布了研究报告《2024Q3盆底、康复逐步企稳，看好医美等新品放量》，本报告对伟思医疗给出买入评级，当前股价为28.59元。展望未来，公司持续改善产品结构，拓展在能量源器械领域的布局，看好公司在医美、康复、泌尿等多个领域的发力，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有9家机构给出评级，买入评级4家，增持评级5家；过去90天内机构目标均价为31.13。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000019753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688580"],"gpt_icon":0},{"id":"2479298776","title":"【机构调研记录】银河基金调研特宝生物、伟思医疗等10只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479298776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479298776?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:06","pubTimestamp":1730246803,"startTime":"0","endTime":"0","summary":"8）恒玄科技 个股亮点：公司主营产品包括TWS耳机芯片。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0239","688278","BK0251"],"gpt_icon":0},{"id":"2479298716","title":"【机构调研记录】鑫元基金调研伊之密、伟思医疗等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479298716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479298716?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:06","pubTimestamp":1730246797,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为鑫元数字经济混合发起式A，最新单位净值为1.12，近一年增长20.66%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300415","688580","BK0251","BK0186"],"gpt_icon":0},{"id":"2479298765","title":"【机构调研记录】恒越基金调研光威复材、伟思医疗等9只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479298765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479298765?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:05","pubTimestamp":1730246730,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月29日披露的机构调研信息，恒越基金近期对9家上市公司进行了调研，相关名单如下：1）光威复材 个股亮点：公司主营产品为碳纤维及织物、碳梁、预浸料、制品；公司是国产碳纤维航空航天应用领域的核心供应商。；公司有光伏用预浸料产品2）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。5）恒玄科技 个股亮点：公司主营产品包括TWS耳机芯片。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0138","BK0208","BK0197","688580","300699","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-21","address":"江苏省南京市雨花台区宁双路19号9栋","stockEarnings":[{"period":"1week","weight":-0.0489},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.3332},{"period":"6month","weight":-0.0364},{"period":"1year","weight":-0.3936},{"period":"ytd","weight":-0.3467}],"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","perCapita":"18135股","boardName":"专用设备制造业","registeredCapital":"9577万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　南京伟思医疗科技股份有限公司主营业务为医疗器械的研发、生产和销售，公司产品主要是MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、多参数生物反馈仪、团体生物反馈仪、表面肌电分析系统、新生儿脑电测量仪、X-walk、X-locom、科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、认知功能障碍治疗软件、伟思云。","serverTime":1732333478364,"listedPrice":67.58,"stockholders":"5281人(较上一季度减少0.58%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}